References
中国2型糖尿病防治指南(2020年版) (上) [J]. 中国实用内科杂志, 2021, 41(8): 668-695.
杨燕, 王德峰. 肠道菌群在糖尿病治疗中的研究进展[J]. 临床荟萃, 2022, 37(10): 953-956.
Gurung, M., Li, Z., You, H., Rodrigues, R., Jump, D.B., Morgun, A., et al. (2020) Role of Gut Microbiota in Type 2 Diabetes Pathophysiology. EBioMedicine, 51, Article ID: 102590. >https://doi.org/10.1016/j.ebiom.2019.11.051
Han, J., Lin, H. and Huang, W. (2011) Modulating Gut Microbiota as an Anti-Diabetic Mechanism of Berberine. Medical Science Monitor, 17, RA164-RA167. >https://doi.org/10.12659/msm.881842
Yang, F., Gao, R., Luo, X., Liu, R. and Xiong, D. (2023) Berberine Influences Multiple Diseases by Modifying Gut Microbiota. Frontiers in Nutrition, 10, Article ID: 1187718. >https://doi.org/10.3389/fnut.2023.1187718
Habtemariam, S. (2020) Berberine Pharmacology and the Gut Microbiota: A Hidden Therapeutic Link. Pharmacological Research, 155, Article ID: 104722. >https://doi.org/10.1016/j.phrs.2020.104722
Wu, J., Yang, K., Fan, H., Wei, M. and Xiong, Q. (2023) Targeting the Gut Microbiota and Its Metabolites for Type 2 Diabetes Mellitus. Frontiers in Endocrinology, 14, Article ID: 1114424. >https://doi.org/10.3389/fendo.2023.1114424
Ma, Q., Li, Y., Li, P., Wang, M., Wang, J., Tang, Z., et al. (2019) Research Progress in the Relationship between Type 2 Diabetes Mellitus and Intestinal Flora. Biomedicine&Pharmacotherapy, 117, Article ID: 109138. >https://doi.org/10.1016/j.biopha.2019.109138
Liu, L., Zhang, J., Cheng, Y., Zhu, M., Xiao, Z., Ruan, G., et al. (2022) Gut Microbiota: A New Target for T2DM Prevention and Treatment. Frontiers in Endocrinology, 13, Article ID: 958218. >https://doi.org/10.3389/fendo.2022.958218
Allin, K.H., Tremaroli, V., Caesar, R., Jensen, B.A.H., Damgaard, M.T.F., Bahl, M.I., et al. (2018) Aberrant Intestinal Microbiota in Individuals with Prediabetes. Diabetologia, 61, 810-820. >https://doi.org/10.1007/s00125-018-4550-1
Letchumanan, G., Abdullah, N., Marlini, M., Baharom, N., Lawley, B., Omar, M.R., et al. (2022) Gut Microbiota Composition in Prediabetes and Newly Diagnosed Type 2 Diabetes: A Systematic Review of Observational Studies. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 943427. >https://doi.org/10.3389/fcimb.2022.943427
张勤, 龙沁, 邓玉玲, 等. 早发2型糖尿病肠道菌群分布特征研究[J]. 中国糖尿病杂志, 2023, 31(2): 113-119.
Chen, Y., Hao, Z., Zhao, H., Duan, X., Jia, D., Li, K., et al. (2022) Berberine Alleviates Intestinal Barrier Dysfunction in Glucolipid Metabolism Disorder Hamsters by Modulating Gut Microbiota and Gut‐Microbiota‐Related Tryptophan Metabolites. Journal of the Science of Food and Agriculture, 103, 1464-1473. >https://doi.org/10.1002/jsfa.12242
Lv, Y., Zhao, X., Guo, W., Gao, Y., Yang, S., Li, Z., et al. (2018) The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus. Journal of Diabetes Research, 2018, Article ID: 1890978. >https://doi.org/10.1155/2018/1890978
Yao, Y., Chen, H., Yan, L., Wang, W. and Wang, D. (2020) Berberine Alleviates Type 2 Diabetic Symptoms by Altering Gut Microbiota and Reducing Aromatic Amino Acids. Biomedicine&Pharmacotherapy, 131, Article ID: 110669. >https://doi.org/10.1016/j.biopha.2020.110669
McCreight, L.J., Bailey, C.J. and Pearson, E.R. (2016) Metformin and the Gastrointestinal Tract. Diabetologia, 59, 426-435. >https://doi.org/10.1007/s00125-015-3844-9
Zhang, W., Xu, J., Yu, T. and Chen, Q. (2019) Effects of Berberine and Metformin on Intestinal Inflammation and Gut Microbiome Composition in Db/db Mice. Biomedicine&Pharmacotherapy, 118, Article ID: 109131. >https://doi.org/10.1016/j.biopha.2019.109131
Lyu, Y., Zhang, Y., Yang, M., Lin, L., Yang, X., Cheung, S.C.K., et al. (2019) Pharmacokinetic Interactions between Metformin and Berberine in Rats: Role of Oral Administration Sequences and Microbiota. Life Sciences, 235, Article ID: 116818. >https://doi.org/10.1016/j.lfs.2019.116818
王君君, 赖诚诚, 张曙光. 阿卡波糖对2型糖尿病肠道菌群及代谢产物的影响[J]. 中国糖尿病杂志, 2022, 30(8): 633-635.
Wang, S., Xu, Z., Cai, B., et al. (2021) Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine. Endocrine, Metabolic&Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine&Metabolic Disorders), 21, 971-979. >https://doi.org/10.2174/22123873mta52oduh1
He, Q., Dong, H., Guo, Y., Gong, M., Xia, Q., Lu, F., et al. (2022) Multi-Target Regulation of Intestinal Microbiota by Berberine to Improve Type 2 Diabetes Mellitus. Frontiers in Endocrinology, 13, Article ID: 1074348. >https://doi.org/10.3389/fendo.2022.1074348
Cheng, H., Liu, J., Tan, Y., Feng, W. and Peng, C. (2022) Interactions between Gut Microbiota and Berberine, a Necessary Procedure to Understand the Mechanisms of Berberine. Journal of Pharmaceutical Analysis, 12, 541-555. >https://doi.org/10.1016/j.jpha.2021.10.003
Zhang, Z., Cong, L., Peng, R., Han, P., Ma, S., Pan, L., et al. (2021) Transformation of Berberine to Its Demethylated Metabolites by the CYP51 Enzyme in the Gut Microbiota. Journal of Pharmaceutical Analysis, 11, 628-637. >https://doi.org/10.1016/j.jpha.2020.10.001
Yue, S., Liu, J., Wang, A., Meng, X., Yang, Z., Peng, C., et al. (2019) Berberine Alleviates Insulin Resistance by Reducing Peripheral Branched-Chain Amino Acids. American Journal of Physiology-Endocrinology and Metabolism, 316, E73-E85. >https://doi.org/10.1152/ajpendo.00256.2018
Wang, H., Zhang, H., Gao, Z., Zhang, Q. and Gu, C. (2022) The Mechanism of Berberine Alleviating Metabolic Disorder Based on Gut Microbiome. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 854885. >https://doi.org/10.3389/fcimb.2022.854885
Lyu, Y., Li, D., Yuan, X., Li, Z., Zhang, J., Ming, X., et al. (2022) Effects of Combination Treatment with Metformin and Berberine on Hypoglycemic Activity and Gut Microbiota Modulation in db/db Mice. Phytomedicine, 101, Article ID: 154099. >https://doi.org/10.1016/j.phymed.2022.154099
Li, C., Cao, H., Huan, Y., Ji, W., Liu, S., Sun, S., et al. (2021) Berberine Combined with Stachyose Improves Glycometabolism and Gut Microbiota through Regulating Colonic MicroRNA and Gene Expression in Diabetic Rats. Life Sciences, 284, Article ID: 119928. >https://doi.org/10.1016/j.lfs.2021.119928
Li, C., Wang, X., Lei, L., Liu, M., Li, R., Sun, S., et al. (2019) Berberine Combined with Stachyose Induces Better Glycometabolism than Berberine Alone through Modulating Gut Microbiota and Fecal Metabolomics in Diabetic Mice. Phytotherapy Research, 34, 1166-1174. >https://doi.org/10.1002/ptr.6588
Wang, S., Ren, H., Zhong, H., Zhao, X., Li, C., Ma, J., et al. (2021) Combined Berberine and Probiotic Treatment as an Effective Regimen for Improving Postprandial Hyperlipidemia in Type 2 Diabetes Patients: A Double Blinded Placebo Controlled Randomized Study. Gut Microbes, 14, Article ID: 2003176. >https://doi.org/10.1080/19490976.2021.2003176
Li, M., Zhou, W., Dang, Y., Li, C., Ji, G. and Zhang, L. (2020) Berberine Compounds Improves Hyperglycemia via Microbiome Mediated Colonic TGR5-GLP Pathway in db/db Mice. Biomedicine&Pharmacotherapy, 132, Article ID: 110953. >https://doi.org/10.1016/j.biopha.2020.110953